Persistence of Pneumocystis carinii after effective treatment of P. carinii pneumonia is not related to relapse or survival among patients infected with human immunodeficiency virus

Clinical Infectious Diseases

Volumn 26, Issue 2, 1998, Pages 509-510

  Roger, P M ^a   Vandenbos, F ^a   Pugliese, P ^a   De Salvador, F ^a   Durant, J ^a   Le Fichoux, Y ^a   Dellamonica, P ^a  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIFAMOLE; PENTAMIDINE;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PNEUMOCYSTIS CARINII; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0031930697     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/517099     Document Type: Article

References (9)